Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI

Inclusion Criteria:

1. Clinical symptoms:

   • Angina < 12 h persistent Angina > 30 min.

2. ECG-Criteria:

   • ST-elevation > 1mm in ≥ 2 extremity leads
   • ST-elevation > 2mm in ≥ 2 contiguous anterior leads
3. Informed consent

Exclusion Criteria:

1. No consent
2. Pregnancy
3. Allergy against abciximab, ASA or heparin
4. Active peptic ulcus ventriculi or duodeni
5. Active non-superficial bleeding
6. Major surgical intervention, intracerebral interventions, puncture central artery < 4 weeks
7. Active internal bleeding
8. Cerebrovascular complications < 2 years
9. Known coagulation disorders, thrombocytopenia
10. Arteriovenous malformations or aneurysms
11. Severe Liver or renal dysfunction
12. Severe untreated hypertension
13. Active vasculitis
14. Previous thrombolysis < 12 h